Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Pharmaceutical company Enlivex Therapeutics (ENLV) completed the initial dosing and follow-up of patients with psoriatic arthritis treated with ...

An expert answers questions about physical therapy for psoriatic arthritis, from what to look for in a provider to what to ...

Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.

This is called psoriatic arthritis, and it can lead to pain in your knees and other joints. Psoriasis is an autoimmune skin condition that causes your skin cells to build up and form dry ...

Although psoriatic arthritis may be more prevalent in White patients, Rebecca Haberman, MD, of NYU Langone Health, emphasizes that the disease affects those across diverse racial and ethnic ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...

The majority of people with psoriatic arthritis first experience skin symptoms. One of the most common is a rash with thick, discolored skin covered with flaky, lighter-colored patches.